Research Governance Policy
|
|
- Garey Scott
- 6 years ago
- Views:
Transcription
1 Research Governance Policy Version: Status: Title of originator/author: Name of responsible director: Developed/revised by group/committee and Date: Approved by group/committee and Date: Effective date of issue: (1 month after approval date) Next annual review date: 1 Final Research & Audit Manager/Research Facilitator Executive Medical Director Research & Development Group Quality Governance Committee, 25 February 25 March January 2016 Date Equality Impact Assessment Completed Regulatory Requirement:
2 Trust Policy Foreword South Western Ambulance Service NHS Foundation Trust (SWASFT) has a number of specific corporate responsibilities and obligations relating to patient safety and staff wellbeing. All Trust policies need to appropriately include these. Health and Safety - SWASFT will, so far as is reasonably practicable, act in accordance with the Health and Safety at Work etc. Act 1974, the Management of Health and Safety at Work Regulations 1999 and associated legislation and approved codes of practice. It will provide and maintain, so far as is reasonable, a working environment for employees which is safe, without risks to health, with adequate facilities and arrangements for health at work. SWASFT employees are expected to observe Trust policy and support the maintenance of a safe and healthy workplace. Risk Management - SWASFT will maintain good risk management arrangements by all managers and staff by encouraging the active identification of risks, and eliminating those risks or reducing them to the lowest level that is reasonably practicable through appropriate control mechanisms. This is to ensure harm, damage and potential losses are avoided or minimized, and the continuing provision of high quality services to patients, stakeholders, employees and the public. SWASFT employees are expected to support the identification of risk by reporting adverse incidents or near misses through the Trust webbased incident reporting system. Equality Act 2010 and the Public Sector Equality Duty - SWASFT will act in accordance with the Equality Act 2010, which bans unfair treatment and helps achieve equal opportunities in the workplace. The Equality Duty has three aims, requiring public bodies to have due regard to: eliminating unlawful discrimination, harassment, victimization and any other conduct prohibited by the Act; advancing equality of opportunity between people who share a protected characteristic and people who do not share it; and fostering good relations between people who share a protected characteristic and people who do not share it. SWASFT employees are expected to observe Trust policy and the maintenance of a fair and equitable workplace. NHS Constitution - SWASFT will adhere to the principles within the NHS Constitution including: the rights to which patients, public and staff are entitled; the pledges which the NHS is committed to uphold; and the duties which public, patients and staff owe to one another to ensure the NHS operates fairly and effectively. SWASFT employees are expected to understand and uphold the duties set out in the Constitution. Code of Conduct and Conflict of Interest Policy - The Trust Code of Conduct for Staff and its Conflict of Interest and Anti-Bribery policies set out the expectations of the Trust in respect of staff behavior. SWASFT employees are expected to observe the principles of the Code of Conduct and these policies by declaring any gifts received or potential conflicts of interest in a timely manner, and upholding the Trust zero-tolerance to bribery. Information Governance - SWASFT recognises that its records and information must managed, handled and protected in accordance with the requirements of the Data Protection Act 1998 and other legislation, not only to serve its business needs, but also to support the provision of highest quality patient care and ensure individual s rights in respect of their personal data are observed. SWASFT employees are expected to respect their contact with personal or sensitive information and protect it in line with Trust policy. Page 1 of 20
3 CONTENTS 1. INTRODUCTION PURPOSE SCOPE OBJECTIVES OF THE TRUST S RESEARCH AND DEVELOPMENT (R&D) FRAMEWORK AND GOVERNING PRINCIPLES RESEARCH FRAUD OR MISCONDUCT MANAGEMENT AND ACCOUNTABILITY STAFF TRAINING AND DEVELOPMENT PROCESS FOR GAINING TRUST MANAGEMENT PERMISSION AMENDMENTS MONITORING AND AUDITING ACTION FOLLOWING COMPLETION OF RESEARCH REVIEW REFERENCES ASSOCIATED DOCUMENTS GLOSSARY APPENDIX A APPENDIX B Page 2 of 20
4 1. Introduction Page 3 of 18 South Western Ambulance Service NHS Foundation Trust (hereafter referred to as the Trust ) acknowledges that research is essential to the successful promotion of health and is a key element of continuous improvement, underpinning the provision of safe and effective evidence-based care. In recognising this, the Trust is committed to developing and supporting a culture of research excellence by observing the requirements set out in legislation and NHS policy. A core standard for healthcare organisations is that they have systems in place to ensure that the principles set out in the Research Governance Framework for Health and Social Care (2nd edition, 2005) are consistently applied, to ensure safe systems of care when research is being undertaken. All research within the scope of the Governance Arrangements for Research Ethics Committees requires review by a Research Ethics Committee (REC). Additionally, to comply with the requirements of the Research Governance Framework, the Trust must formally approve all research activities in which it participates. This policy reflects the role that the Trust increasingly plays in delivering key services that are based not on historical precedent, scientific uncertainty or individual preference - but on sound evidence. It reinforces the importance of building high-quality, research-based practice that lays the foundation for our greater contribution to NHS priorities - with the goal of finding new, more effective techniques and eradicating unsafe or inefficient practices and interventions. 1.1 Definition of Research Research can be defined as the attempt to derive widely applicable new knowledge by addressing clearly defined questions with systematic and rigorous methods. 1.2 Today s Research May be Tomorrow s Practice Key characteristics of NHS Research and Development (R&D) projects include that they should be: 2. Purpose relevant to the NHS; generalisable; protocol-driven; valid; peer-reviewed. The purpose of this policy is to develop, support and sustain a culture of research excellence by: setting standards for the participation, operation and conduct of research;
5 3. Scope Page 4 of 20 defining the mechanisms to ensure that these standards are being met; establishing arrangements for the monitoring and assessment of all research; ensuring that research and development activity is an integral part of the Trust s Clinical Governance arrangements for quality care and evidencebased services, responsive to all needs and involving the users, carers and communities we serve. 3.1 This policy applies to all research activity within the Trust involving its premises; patients, carers, users and staff (including their tissues and data, both past and present); and to all studies where the Trust has agreed to act as the sponsor. In addition, it sets out processes for:- effective management and accountability of all research undertaken within the Trust; ensuring those undertaking research are appropriately guided, supported and supervised; ensuring that the appropriate approvals are in place before any research activity commences; progressing research projects from proposal to completion; reporting and disseminating research outcomes; the evaluation of individual research projects and the research and development programme as a whole. 3.2 Activities such as clinical audit, clinical innovations, service evaluations and local developments of existing research are not within the scope of this policy and will not be managed as research. Advice may be sought from the Research & Audit Department regarding the classification of individual projects. An algorithm differentiating research from audit and service evaluation is included in Appendix A. 4. Objectives of the Trust s Research and Development (R&D) Programme 4.1 The Trust is committed to developing a robust research programme through which it can discharge its duties in terms of research as set out in the Health and Social Care Act The primary objectives of the R&D programme are to: develop the R&D capacity, culture and framework to assist the Trust in the delivery of evidence-based clinical practice, ensuring that decisions are based on sound facts drawn from managed and co-ordinated R&D activity; enable the Trust and its staff to influence national NHS R&D priorities and to actively encourage the Trust s own R&D activity, focusing on areas requiring improvement; promote a culture of learning that ensures staff have a contemporary and empirical understanding of evidence-based practice to support operational and clinical effectiveness; involve service users in the setting of the R&D agenda and explore
6 opportunities for the effective dissemination of research outcomes to participants, employees and the public; develop and manage a Trust-wide portfolio of quality, high-level R&D in association with health, education and social care partners, submitting joint applications to agencies where appropriate. 5. Framework and Governing Principles 5.1 Use of Patient Data The handling of personal information in research must be compliant with the Trust s Information Governance Policy and with the Data Protection Act All use of patient data for research purposes requires the consent of the patient. There are some exceptions where patient data can be used without consent under Section 60 of the Health and Social Care Act Requests for this use are now through the National Information Governance Board for Health and Social Care (NIGB). An application for approval to use identifiable patient data to the NIGB may be made simultaneously with the application to the REC and for Trust Permission. 5.2 Clinical Trials of Investigational Medicinal Products All Clinical Trials of Investigational Medicinal Products (CTIMPs) must be conducted in line with the EU Clinical Trials Directive 2004, transposed into UK law by the Medicines for Human Use (Clinical Trials) Regulations It is a statutory requirement that all CTIMP studies have in place a favourable opinion from a recognised REC and a notice of no objection from the Medicines and Healthcare Products Regulatory Agency (MHRA) prior to commencement. 5.3 Clinical Investigations of Medical Devices For clinical investigations of a non-ce Marked medical device (i.e. a new or substantially modified device, or an existing device with new function, feature or material) or a CE Marked device being used for a new intended purpose, a notice of no objection is required from the MHRA Devices Division in line with the Devices Regulations prior to commencement of the study. 5.4 Adults Lacking Capacity to Consent to Anyone carrying out research to which the requirements of the Mental Capacity Act 2005 (MCA) apply must act in accordance with the provisions of the Act in order for the research to be lawful. The MCA provides a statutory framework for people who may not be able to make their own decisions, for example because of learning difficulties, brain injury or mental health problems. It also covers temporary loss of capacity such as confusion, loss of consciousness, stroke, heart attack and delirium. It sets out who can take decisions, in which situations, and how they should go about this. Page 5 of 20
7 5.5 Ethics Page 6 of 20 The dignity, rights, safety and welfare of participants must be primary considerations in any research study. All research must be informed by due consideration of ethical responsibilities towards participants and patients. A favourable opinion from an appropriately recognised REC is required for all research projects involving NHS patients, users, relatives or carers (including their organs, tissue and data). RECs are not accountable in any way to NHS Trusts, and in particular are separate from Trust R&D Departments in respect of their decisionmaking. 5.6 Science Adequate background or preparatory work is essential before starting any research project. Research which duplicates other work unnecessarily is itself unethical, wastes resources, can have a negative impact on participants and could possibly bring the Trust into disrepute. All proposals for research must be subjected to review by experts in the relevant fields who are able to offer independent advice on its quality. A copy of the peer review report should be submitted for all research projects prior to the commencement of the application process for Trust Permission and/or REC approval. Research-related data should be retained for a period of five years to enable further analysis by the original, or other, research teams, subject to appropriate consent for its use being in place, or this not being a requirement. 5.7 Patient and Public Involvement 5.8 Information Participants or their representatives should be involved wherever possible in the design, conduct, analysis and reporting of research. Service users and members of the public shall have reasonable access to information about any research being undertaken by the Trust. Such information may be in the form of research reports, articles, or leaflets; made available through presentations and/or seminars, or via the Trust s website. All information should be presented in a format and language which is suitable for the intended audience. All research must be open to critical review and appropriate monitoring. Researchers must familiarise themselves with the requirements of the Data Protection Act and other legal provisions and guidance on handling information. 5.9 Health and Safety The safety of participants and of research and other staff must be given priority at all times. Researchers need to be aware of their responsibilities under Health and Safety Legislation both in respect of themselves, colleagues and research participants.
8 Page 7 of 20 Health and Safety considerations will be addressed through risk assessment of research activities where appropriate. The Trust policy procedure (and other legislative and policy requirements where appropriate), for the reporting of accidents, adverse and dangerous incidents must be followed and will be used to record any adverse events arising from the research process Finance and Intellectual Property 5.11 Sponsorship All researchers must comply with the procedures of the Trust s Finance Department in planning and accounting for all expenditure, together with audit processes and dealing with fraud. Arrangements for the management of intellectual property arising from R&D are dealt with under the Trust s Business Code of Conduct. All findings and intellectual property from research conducted by employees of the Trust will remain the property of the Trust, although it is recognised that statute provides copyright may be assigned to the author of work intended for publication in a professional or academic journal or electronically. The Trust however reserves the right to itself, at no cost, reproduce and use these publications for its own non-commercial purposes, including for further research and training. Research findings and intellectual property arising from research which is externally funded will be subject to contractual agreement with the research funder/sponsor and/or employing organisation. Funding for research activity must be identified and confirmed prior to an application for Trust Management Permission to conduct a research project. All research conducted within the NHS requires a research sponsor. The sponsor or sponsoring organisation is responsible for securing the arrangements for the initiation, management, monitoring and financing of a study. In addition, the research sponsor needs to be satisfied that: the proposal is worthwhile and of high scientific value; the quality of the research environment has passed appropriate quality assurance standards; and that the key researchers have adequate experience and expertise to conduct the research. Where it is the intention that the Trust be identified as the Sponsor for a project, early contact with the Research & Audit Department is essential in order for the necessary agreement to be obtained. 6. Research Fraud or Misconduct 6.1 Research fraud or misconduct has been defined as Falsification, plagiarism or deception in proposing, carrying out or reporting results of research. It also includes serious breaches of protocol of Good Clinical Practice (GCP). Research misconduct may include the following, whether deliberate, reckless or negligent: Fabrication, falsification or corruption of research data; Distortion of research outcomes by distortion or omission of data; Dishonest misinterpretation of results; Publication of data known or believed to be false or misleading;
9 Unauthorised use of information which was acquired confidentially; Plagiarism, or dishonest use of unacknowledged sources; Misquotation or misrepresentation of other authors; Inappropriate attribution of authorship; Misconduct in relation to grant applications and fund utilization; Failure to obtain appropriate permission to conduct research; Fraud or other misuse of research funds or research equipment; Unethical behaviour in the conduct of research, e.g. in relation to research subjects. All cases of suspected fraud or misconduct are to be reported in accordance with the Trust s procedures. The general principles are: Allegations should be in writing and should be made at the earliest opportunity; Allegations should be reported to the Research & Audit Department and to the Executive Medical Director; Allegations will be investigated and outcomes recorded by the Research & Audit Department; Allegations and investigation outcomes will be reported to the Quality Governance Committee (QGC); In the event of serious allegation or continuing non-compliance with terms of the project approval, the approving REC and the Strategic Health Authority will be informed; Where a healthcare professional (clinical or social work) is involved in research misconduct the matter will be reported to the appropriate professional body. 7.1 Management and Accountability Figure 1 illustrates the management and accountability structure for research and development activity. Individuals Working on Research Projects Principal Investigator for study Research & Development Group Clinical Effectiveness Group Quality Governance Committee Executive Medical Director Trust Board Page 8 of 20 Figure 1 - Accountability for Research and Development All organisations conducting, sponsoring, funding or hosting health and social All organisations conducting, sponsoring, funding or hosting health and social care research must have systems to ensure that they and their staff understand and follow the standards set out in the Research Governance Framework for Health and Social Care. The Chief Executive holds ultimate accountability on behalf of the Board for research and development activity, and delegates responsibility for the quality, management and delivery of the research programme to the Executive Medical Director. The Executive Medical Director is responsible for overseeing and monitoring research and development activity within the Trust. The Executive Medical Director is the authorised signatory for letters giving Management Permission for research to commence.
10 Page 9 of 20 The Research & Development Group is responsible for approving the annual Trust programme of research and development, and considering the approval of proposals for research and development generated from Trust staff and external organisations. The Clinical Effectiveness Group (CEG) will receive reports of all research projects receiving Trust Management Permission. The Quality Governance Committee (QGC) will receive reports from the Clinical Effectiveness Group and will in turn provide updates to the Board. The Research & Audit Manager will comprise the named contact for all outside links such as with Higher Education Institutions and other NHS organisations, NRES and research sponsors. The Research & Audit Department must be notified of, and submit to, the R&D Group for approval, all research conducted within the Trust, ensuring that all the relevant procedures are followed, monitored and reported to the R&D Group. In addition the Research & Audit Department will offer guidance and professional support to others undertaking research within the Trust and produce an annual review of research within the Trust. The Chief Investigator (CI) has overall responsibility for the conduct of the research. In multi-site studies, the CI has responsibility for co-ordinating the research across the sites. The Principal Investigator (PI) has overall responsibility for the research at a particular site. In single-site studies, the CI and the PI will usually be the same person. All Researchers/Investigators have a responsibility to adhere to this policy, the conditions of Trust Management Permission, current legislation and policy requirements relating to the research, other approvals in place for the study and to conduct all activity in line with the study protocol. Students should make contact with the Research & Audit Department before commencing any research activity involving Trust staff, patients (including their data), premises or resources, to ensure that the appropriate approvals and permissions are in place. Clinical Staff and Managers are encouraged to engage in the research and development process. This may take the form of contributing data to ongoing projects or initiating and carrying out projects individually or in teams. 8. Staff Training and Development 8.1 Appropriate staff training and development will be provided to improve knowledge of the research process, systems, guidance and support available so as to develop capacity, expertise and skills required to undertake research. 8.2 All staff working on Clinical Trials of Investigational Medicinal Products (CTIMPs) should hold a certificate of Good Clinical Practice (GCP). These staff are required to update their GCP training when legislation has changed, new policies or practice
11 Page 10 of 20 have been implemented, different research activities are to be undertaken, or a significant period of time has elapsed since research activities have been conducted. 8.3 Trust staff working on projects other than CTIMPs should ensure that they have received training appropriate to their role and the research tasks and responsibilities allocated. All staff working on research projects within the Trust are encouraged to attend GCP training and this is a requirement for those acting as PIs. Training should be updated as per 8.2 above. 8.4 Where researchers are employed by the Trust, compliance with this policy will be a condition of employment. All staff are encouraged to engage in the research process. This may include activities such as contributing data to on-going projects or initiating and carrying out their own research. Staff participation in research projects will be voluntary; additionally, they will have the right to opt out at any stage - in line with the approved project protocol. 9. Process for Gaining Trust Management Permission 9.1 Research activity involving Trust staff, patients (including their data), facilities or resources may not be initiated without formal Trust Management Permission, signed by the Executive Medical Director. Early contact with the Research & Audit Department for guidance regarding the process for obtaining this permission is recommended. 9.2 Applications will be reviewed and assessed by the Research & Development Group. Agreement in principle may be given following this review and the application may then be completed. 9.3 Applications should be made by the CI/PI and should be completed in the Integrated Research Application System (IRAS), accessed from The application pack for Trust Permission will comprise: the R&D form in IRAS, the Site Specific (SSI) form in IRAS & the supporting documentation as specified in the R&D submission checklist in IRAS. 9.5 Applications should be made through the Coordinated System for Gaining NHS Management Permission (CSP) where studies have been adopted into the National Institute for Health Research (NIHR) portfolio (once agreement in principle has been obtained); further details and guidance are provided in the submissions tab in IRAS. 9.6 Applications not eligible for inclusion in the NIHR portfolio should be made directly to the Research & Audit Department. 9.7 The application for Trust Management Permission and REC review may be made simultaneously, providing agreement in principle from the R&D Group has been obtained. 9.8 All applications should be completed in line with the guidance provided by the Research & Audit Department staff. A checklist of required documentation is
12 available in the submission tab in IRAS. 10. Amendments 10.1 The Trust SOP for amendments to research projects should be followed and the appropriate submission should be made prior to the amendment being implemented. Amendments defined as substantial will in most cases, also need to be submitted to the REC and/or the MHRA prior to implementation. 11. Monitoring and Auditing 11.1 All research activity will be routinely monitored. In addition, NHS organisations are required to conduct formal audit of a selection of research projects. The Department of Health s minimum standards for research governance state that at least 10% of projects should be routinely audited A project will also be audited if there is any suspicion of reduced research governance standards in a project It should be noted that this monitoring is in addition to summary reports of research progress that should be submitted to the Trust by the CI/PI on an annual basis. 12. Action Following Completion of Research 12.1 Following completion of any research project, the outcomes should be presented, as far as is reasonably practicable, to a meeting of the Trust s R&D Group. Further presentations may be required to other Trust committees or working groups or external stakeholder organisations The outcome of any research should be considered to improve Trust practice Research projects should normally be considered for publication in appropriate media. Particular consideration should be given to publication in peer-reviewed journals Guidance and support in preparing papers for publication will be available to researchers from the Research & Audit Department In circumstances where an author or co-author is a Trust employee and publication of research is likely to attract media attention, the Public Involvement and Relations Manager should be consulted and briefed in advance. In some circumstances, the Chief Executive should be informed The stages of the process from submitting an application for Trust Management Permission to conduct research, through to the dissemination of findings is illustrated in Figure 2. Page 11 of 20
13 1) Idea for research Research Design Services (RDS) assist with forming research proposals and funding applications 2) Preliminary work e.g. Literature search and methodology. Commence application process in IRAS SWAST Research and Audit Department assist with formulating research ideas, and with REC and Trust applications 3) Obtain agreement in principle from R&D Group 4) Complete application in IRAS and submit for Trust Permission and REC approval PenCLRN Can help CI with writing applications and chasingup delayed decisions. Also can monitor progress of approvals etc. at participating sites if we are the lead site 7) Project Commences Fig 3. 6) Notification of approval sent to PI 5) Governance checks completed by Research and Audit Department/CLRN 8) Ongoing monitoring by Trust and Regulatory bodies 9) Annual Reports to Trust and REC 10) Study completed Final report to Trust and REC Dissemination of findings Fig 2. Page 12 of 20
14 13. Review 13.1 The Research Governance Policy will be reviewed every three years, with the next review due in January References 1. Comprehensive Clinical Research Network: Page 13 of Coordinated System for Gaining NHS Permission overview, process and guidance: 3. Governance arrangements for research ethics committees: a harmonised edition, May 2011: nce/dh_ Health Research Authority (HRA) : 5. INVOLVE Patient and Public Involvement 6. Medicines and Medical Devices Regulation what you need to know: 7. Medicines for Human Use (Clinical Trials) Regulations Mental Capacity Act 2005, Code of Practice: 9. National Information Governance Board for Health and Social Care (NIGB): National Research Ethics Service Research or Audit?: Research Governance Framework for Health and Social Care Second edition, nce/dh_ Standard Operating Procedures for Research Ethics Committees, v 5.1, Mar 2012: The UK Code of Practice for Research - Promoting good practice and preventing misconduct, September 2009:
15 15. Associated Documents This policy links to: Governance Strategy Incident Reporting Policy Information Governance Policy Protocol for Sharing and Disclosing Information Quality Strategy 16. Glossary Chief Investigator (CI): the investigator with overall responsibility for the design, conduct and reporting of a study. Comprehensive Clinical Research Network (CCRN): is made up of 25 Comprehensive Local Research Networks (CLRNs) which cover the whole of England by region. The Trust straddles two of these networks the Peninsula and Western CLRNs. The networks coordinate and facilitate the conduct of clinical research and provide a wide range of support to the local research community. Page 14 of 20 Good Clinical Pracice (GCP): The principles of Good Clinical Practice in Clinical Trials as set down in Articles 2-5 of the GCP Directive and implemented in the UK by Schedule 1 of the Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I.2004/1031) as amended by S.I. 2006/1928. Good Clinical Practice is a set of internationally recognised ethical and scientific quality requirements which must be observed for designing, conducting, recording and reporting clinical trials that involve the participation of human subjects. Health Research Authority (HRA): is a newly formed NHS organisation established on 01 December 2011 as a Special Health Authority. The purpose of the HRA is to protect and promote the interests of patients and the public in health research. Indemnity: provides protection against any action by an individual, a group or an organisation that believe they received bad or negligent services, and incurred a loss as a result. Most professional bodies have professional indemnity cover; in some cases it is compulsory. The limit of an indemnity policy relates to the maximum amount of money that an individual or organisation will pay out in the event of a claim being made. Integrated Research Application System (IRAS): a single system for applying for the permission and approvals for health and social care research in the UK. See International Conference on Harmonization of Good Clinical Practice (ICH GCP): an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected; consistent with the principles that have their origin in the Declaration of Helsinki, and that clinical trial data are credible. See Medicines and Healthcare products Regulatory Agency (MHRA): the Executive Agency of the Department of Health protecting and promoting public health and patient safety by ensuring that medicines, healthcare products and medical equipment meet appropriate standards of safety, quality, performance and effectiveness, and are used safely. See
16 Also encompassing the MHRA Devices Division: Mental Capacity Act 2005: places clear responsibilities on researchers regarding the inclusion of participants lacking in capacity. ( Monitoring: the act of overseeing the progress of a clinical trial, and of ensuring that it is conducted, recorded, and reported in accordance with the protocol, standard operating procedures (SOPs), GCP, and the applicable regulatory requirement(s). The purposes of trial monitoring are to verify that: a) the rights and well- being of human subjects are protected. b) The reported trial data are accurate, complete and verifiable from source documents c) The conduct of the trial is in compliance with the currently approved protocol / amendments(s), with GCP, and with the applicable regulatory requirements. National Institute for Health Research (NIHR): undertakes to create a health research system in which the NHS supports leading edge research, providing the systems and infrastructure needed to support this. It also commissions and funds NHS and Social Care Research and provides systems to streamline and unify the activity. The role of the research strand of the NIHR is to develop the research evidence to support decision-making by professionals, policy-makers and patients, make this evidence available, and encourage its uptake and use. National Institute for Health Research Clinical Research Network Portfolio: the national database of research projects which have been accepted as meeting the minimum requirements for inclusion in the portfolio and are therefore eligible for NHS support via the NIHR. National Institute for Health Research Coordinated System for Gaining NHS Management Permission (NIHR CSP): is a single point of entry for investigators wishing to apply for NHS Permission for single or multi site studies. It may only be used for studies which have been adopted into the UK Clinical Research Network Study Portfolio. Principal Investigator: the investigator responsible for research at an individual site. Protocol: A document that describes the objective(s), design, methodology, statistical considerations, and organisation of a trial. The protocol usually also gives the background and rationale for the trial, but these could be provided in other protocol referenced documents. Research Ethics Committees (RECs): review research proposals which fall within their remit as defined in the Governance Arrangements for Research Ethics Committees and as required due to legislation. Research Site: the single organisation responsible for hosting the research at a particular locality. One or more locations within a single organisation, such as an NHS Trust, will usually be considered as a single site. Page 15 of 20
17 Sponsor: The sponsor is the individual, or organisation (or group of organisations) that takes on responsibility for confirming there are proper arrangements to initiate, manage and monitor, and finance a study. All research taking place within the NHS requires that a Sponsor has agreed to take on these responsibilities prior to any research activity taking place. Trust Permission Letter: letter confirming that NHS Permission has been given and the study can commence. Page 16 of 20
18 Appendix A Differentiating Research, Audit & Service Evaluation* RESEARCH CLINICAL AUDIT SERVICE EVALUATION The attempt to derive generalisable new knowledge including studies that aim to generate hypotheses as well as studies that aim to test them. Quantitative research designed to test a hypothesis. Qualitative research identifies/explores themes following established methodology. Addresses clearly defined questions, aims and objectives. Quantitative research -may involve evaluating or comparing interventions, particularly new ones. Qualitative research usually involves studying how interventions and relationships are experienced. Usually involves collecting data that are additional to those for routine care but may include data collected routinely. May involve treatments, samples or investigations additional to routine care. Quantitative research - study design may involve allocating patients to intervention groups. Qualitative research uses a clearly defined sampling framework underpinned by conceptual or Designed and conducted to produce information to inform delivery of best care. Designed to answer the question: Does this service reach a predetermined standard? Measures against a standard. Involves an intervention in use ONLY. (The choice of treatment is that of the clinician and patient according to guidance, professional standards and/or patient preference.) Usually involves analysis of existing data but may include administration of simple interview or questionnaire. No allocation to intervention groups: the health care professional and patient have chosen intervention before clinical audit. Designed and conducted solely to define or judge current care. Designed to answer the question: What standard does this service achieve? Measures current service without reference to a standard. Involves an intervention in use ONLY. (The choice of treatment is that of the clinician and patient according to guidance, professional standards and/or patient preference.) Usually involves analysis of existing data but may include administration of simple interview or questionnaire. No allocation to intervention groups: the health care professional and patient have chosen intervention before service evaluation. theoretical justifications. May involve randomisation No randomisation No randomisation ALTHOUGH ANY OF THESE THREE MAY RAISE ETHICAL ISSUES, UNDER CURRENT GUIDANCE:- RESEARCH REQUIRES R.E.C. REVIEW AUDIT DOES NOT REQUIRE REC REVIEW SERVICE EVALUATION DOES NOT REQUIRE REC REVIEW *Table taken from NRES website Research or Audit Page 17 of 18
19 Appendix B Standard Conditions of Trust Management Approval for Research Conducted at South Western Ambulance Service NHS Trust ( the trust ). You may only conduct or participate in research involving the Trust s patients or using the Trust s staff, premises or equipment in accordance with the relevant protocol, terms and conditions of the approval of the relevant Research Ethics Committee (REC) and which has been authorised by the MHRA (if applicable). Permission is only granted for those activities for which a favourable opinion has been given by the REC. In addition to complying with all the Trust s Policies and Procedures generally, in carrying out research you must comply with the Trust s local reporting requirements, systems, policies, procedures, and protocols for implementation of the Research Governance Framework. The Trust manages all research in accordance with the Research Governance Framework for Health & Social Care and compliance by you, with this Framework, is a requirement of this Trust Permission. The Framework sets out the roles and responsibilities of individuals and organisations and standards that should be applied to work managed within the formal research context. A direct link to these standards is available on the Department of Health s website at: Data Protection & patient Confidentiality You should make a reasonable and appropriate effort to understand any project issues that may arise due to the Data Protection Act 1998 and other legal provisions and guidance on handling information, seeking expert advice where necessary and you should ensure that the agreed counter measures described in your SSI form and supporting documentation are kept in place in order that the project does not breach any of the principles outlined in the Data Protection Act Protocol Amendments All amendments (including changes to the local research team) need to be submitted in accordance with guidance in IRAS before the changes are implemented locally. Protocol Deviations/Urgent Safety Measures The research sponsor or the Chief Investigator, or the local Principal Investigator at a research site, may take appropriate urgent safety measures in order to protect research participants against any immediate hazard to their health or safety. The R&D office and Sponsor should be notified that such measures have been taken. The notification should also include the reasons why the measures were taken and the plan for further action. The Research and Audit Department, Sponsor, REC and any other regulatory bodies should be notified within the same time frame. Protocol Violation Any protocol violation resulting from error, fraud or misconduct should be notified to the Executive Medical Director and the Research and Audit Department as soon as you become aware of it. Notification of Adverse Events/Safety Reporting All adverse events/incidents are to be reported in accordance with the Trust s Incident Reporting Policy and Serious Incident Policy (and other legislative and policy requirements where appropriate) using the Trust s Incident Reporting Form stating clearly in the text box that the incident is research-related. Indemnity Trust Permission is given on the basis that indemnity arrangements are in place as detailed in the application and supporting information and that these remain in place for the duration of the study. Page 18 of 20
20 Research Audit, Monitoring & Reporting You should ensure that requests for reports on the progress and outcomes of the work required by those with a legitimate interest (such as the regulatory body, the Sponsor, the Funder(s), the Research Ethics Committee and the Trust) are produced on time and to an acceptable standard and that all data and documentation associated with the study are available for audit at the request of the appropriate authority. You should provide an annual progress report to the Research and Audit Department, the first being due one year after Trust Permission is given for the study. A summary of the final report on the research should be submitted within one year of the conclusion of the research. The report should detail whether the study achieved its objectives, the main findings, and arrangements for publication or dissemination of the research including any feedback to participants. All NHS organisations are required to monitor research to ensure compliance with the Research Governance Framework and other legal and regulatory requirements. This is achieved by a random audit of research projects. Finance You should ensure that any research income is managed in accordance with the agreed financial arrangements. Honorary Contracts/Letters of Access You should ensure that anyone engaged in the research involving the Trust s patients, users, carers or staff, who is not employed by the Trust has an honorary contract or Letter of Access to give them permission to attend the Trust s premises, or have access to records for the required purposes. If you have been advised that you should complete a Research Passport application (or any member of the local research team), then you are responsible for ensuring that this is done and submitted in accordance with Trust policy and the published Research Passport guidance. The relevant individuals must not commence any research activities involving the Trust until the appropriate contractual agreements are in place for them. The site Principal Investigator must ensure that they actively monitor professional registration of any HRC holders who are working under their supervision. Changes to the Project Status and to the Membership of the Research Team You should notify the Research & Audit Department immediately if you are no longer able to continue as Chief Investigator/site Principal Investigator/Local Collaborator and/or if there is a change to project status such as a temporary halt or early termination. Archiving The Principal Investigator is responsible for ensuring that there are suitable archiving arrangements in place at the end of the study that ensures the study s essential documents are safe and secure and are accessible on request by the sponsor, the Trust or any other authority with a legitimate interest. The minimum length of time that the study s essential documents should be kept for is 5 years after the study has closed. Review of Trust Management Permission Trust Permission may be reviewed at any time in the light of any relevant information received. Breach of Permission Conditions Failure to comply with these conditions may lead to suspension or termination of Trust Management Permission and the relevant Research Ethics Committee shall be informed. v Page 19 of 20
Grievance Policy. Version: 2.3. Status: Final. Title of originator/author: Human Resources Directorate. Name of responsible director:
Grievance Policy Version: 2.3 Status: Title of originator/author: Name of responsible director: Developed/revised by group/committee and Date: Approved by group/committee and Date: Final Human Resources
More informationCODE OF PRACTICE FOR RESEARCH
CODE OF PRACTICE FOR RESEARCH Dr Diana Leighton REF Manager Professor Andy Young Director of Research & Innovation Services Version 1.0 - September 2010 First approved Academic Board 27 September 2010
More informationSponsorship of Clinical Research Studies
Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use
More informationMRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council
MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR
More informationDisciplinary Policy and Procedure
Disciplinary Policy and Procedure Version 2.5 Important: This document can only be considered valid when viewed on the Trust website. If this document has been printed or saved to another location, you
More informationCode of Conduct for Staff
Diocese of Bristol Academies Trust Code of Conduct for Staff Date Adopted: 4 th June 2015 Date Reviewed:.v 1 Final Page 1 History of most recent Policy changes (must be completed) Date Page Change Origin
More informationTrial oversight SOP for HEY-sponsored CTIMPs
R&D Department Trial oversight SOP for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored in a retrieval system
More informationDATA QUALITY POLICY. Version: 1.2. Management and Caldicott Committee. Date approved: 02 February Governance Lead
DATA QUALITY POLICY Version: 1.2 Approved by: Date approved: 02 February 2016 Name of Originator/Author: Name of Responsible Committee/Individual: Information Governance, Records Management and Caldicott
More informationConditions of Award. Royal Society Newton International Fellowships funded under the Newton Fund
Conditions of Award Royal Society Newton International Fellowships funded under the Newton Fund These Conditions of Award set out the standard terms and conditions for all Royal Society Newton International
More informationHonorary Contracts Procedure
Honorary Contracts Procedure Version: 3.0 Bodies consulted: Approved by: Joint Staff Consultative Committee & WMT Executive Management Team Date Approved: 03 October 2017 Lead Manager: Responsible Director:
More informationHow to Apply for Ethics (Non-CTIMPs) including Sponsorship
How to Apply for Ethics (Non-CTIMPs) including Sponsorship Joint Research & Enterprise Office (JREO) St George s University of London Lucy H H Parker Clinical Research Governance Manager Joint Research
More informationConditions of Award. Royal Society Funding Schemes
Conditions of Award Royal Society Funding Schemes These Conditions of Award set out the standard terms and conditions for all Royal Society Awards. The Conditions of Award should be read in conjunction
More informationCode of Conduct INTRODUCTION
INTRODUCTION Kingspan Group plc is committed to acting responsibly in its business, and maintaining high standards of ethics and integrity in all its dealings with its stakeholders, be they investors,
More informationConfirming Research Study Capacity and Capability
Title: Outcome Statement: Written By: Confirming Research Study Capacity and Capability Researchers will be informed about the procedures and requirements for obtaining permission to conduct a research
More informationCODE OF CONDUCT. Document Management
CODE OF CONDUCT Document Management This document is available in multiple languages and may be updated from time to time. For the avoidance of doubt, it is therefore explicitly mentioned that the English
More informationPolicy and procedure for the disclosure of information in the public interest (Whistleblowing in the NHS)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY Policy and procedure for the disclosure of information in the public interest (Whistleblowing in the NHS) Responsible Officer
More informationCode of Corporate Governance
Code of Corporate Governance 1 FOREWORD From the Chairman of the General Purposes Committee I am pleased to endorse this Code of Corporate Governance, which sets out the commitment of Cambridgeshire County
More informationFixed Term Staffing Policy
Fixed Term Staffing Policy Who Should Read This Policy Target Audience All Trust Staff Version 1.0 October 2015 Ref. Contents Page 1.0 Introduction 4 2.0 Purpose 4 3.0 Objectives 4 4.0 Process 4 4.1 Recruitment
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Archiving and the Destruction of Records SOP-RES-028 Version Number 2 Issue Date 08 th Dec 2015 Effective Date 22 nd January 2016 Review Date 22 nd January
More informationDevelopment Safety Update Report Guidance
Development Safety Update Report Guidance This document provides instructions for the preparation and submission of a Development Safety Update Report (DSUR) for a Clinical Trial of an Investigational
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate. Indicator Process Guide. Published December 2017
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Indicator Process Guide Published December 2017 Please note that this is an interim factual update to the NICE Indicator
More informationR&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:
Research as a Participating site STANDARD OPERATING PROCEDURE FOR OVERSIGHT SOP No: P08/PF2 V2 Effective Date: 31 st July 2013 Supersedes: P08/PF2 Revision Date: 31 st March 2014 Author: Position: Approved
More informationStudy Files and Filing
Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm
More informationRole Title: Chief Officer Responsible to: CCG chairs - one employing CCG Job purpose/ Main Responsibilities
Role Title: Chief Officer Responsible to: CCG chairs - one employing CCG Job purpose/ Main Responsibilities Accountable to: All employed staff working within the 3 CCGs Within the 3 CCGs the Chief Officer
More informationThe EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland Question 1: What laws or regulations apply to an application for conducting a clinical
More informationAudit & Risk Committee Charter
Audit & Risk Committee Charter Status: Approved Custodian: Executive Office Date approved: 2014-03-14 Implementation date: 2014-03-17 Decision number: SAQA 04103/14 Due for review: 2015-03-13 File Number:
More informationCode of Conduct. Human Resources Policies and Procedures. UCD/HRO/Conduct/048
1NHSBT Code of Conduct UCD/HRO/Conduct/048 Version Issued: February 2013v1.1 Human Resources Policies and Procedures Code of Conduct UCD/HRO/Conduct/048 1 Policy UCD/HRO/Conduct/048 Title NHSBT Code of
More informationSTANDARD OPERATING PROCEDURE SOP 310
STANDARD OPERATING PROCEDURE SOP 310 DEVELOPMENT OF PARTICIPANT INFORMATION SHEET AND INFORMED CONSENT FORM Version 1.3 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 8 Review date April
More informationHEALTH AND SAFETY STRATEGY
HEALTH AND SAFETY STRATEGY 2016-2019 Version: 1.0 Ratified by: Integrated Governance Committee Date ratified: 30 September 2015 Title of originator/author: Title of responsible committee/group: Head of
More informationCode of Conduct. Integral Diagnostics Limited ACN
Code of Conduct Integral Diagnostics Limited ACN 130 832 816 Date: 1 October 2015 Code of Conduct Part A Scope and application 1 Purpose of the Code The Company is committed to a high level of integrity
More informationHumber Information Sharing Charter
External Ref: HIG 01 Review date November 2016 Version No. V07 Internal Ref: NELC 16.60.01 Humber Information Sharing Charter This Charter may be an uncontrolled copy, please check the source of this document
More informationResearch Ethics Governance Policy
Research Office Research Ethics Governance Policy University of West London: Research Office, June 2008 Updated June 2015. Please note: 1. The information given in this publication is accurate at the time
More informationSTAFF CODE OF CONDUCT
STAFF CODE OF CONDUCT 1. INTRODUCTION Our College will only succeed in achieving our objectives where we have the respect of our stakeholders, (including our students, parents and colleagues) and the communities
More informationBowmer. & Kirkland. Kirkland. & Accommodation. Health & Safety Policy.
Bowmer Kirkland & Kirkland & Accommodation Health & Safety Policy December 2013 www.bandk.co.uk Index Policy Statement Page 3 Interaction of Health and Safety Responsibilities Page 5 Organisation Page
More informationGlobal Supplier Code of Conduct
Global Supplier Code of Conduct Message from our Chief Executive Officer At Rolls-Royce our strategy focuses on customer, innovation and profitable growth to ensure a sustainable business. This includes
More informationChild and Family Agency. Research Ethics Committee Guidelines
1 Child and Family Agency Research Ethics Committee Guidelines June 2015 1. Overview 1.1 The Child and Family Agency s commitment to high-quality, ethical research guides the Agency s first Research Strategy
More informationTerms of Reference for Mind Committees
Terms of Reference for Mind Committees General notes relating to all committees 1. Committee Structure 1.1. The trustees at a Council of Management meeting in accordance with its Memorandum and Articles
More informationInvestigational Medicinal Product (IMP) Management Standard Operating Procedure
Reference Number: UHB 040 Version Number: 3 Date of Next Review: 26 Apr 2019 Previous Trust/LHB Reference Number: T 363 Standard Operating Procedure Introduction and Aim This procedure is written to support
More informationWork Placement Handbook for Graduate Diploma in New Zealand Immigration Advice
Work Placement Handbook for Graduate Diploma in New Zealand Immigration Advice For Students and Work Placement Mentors Adapted with permission from material supplied by Eastern Institute of Technology
More informationDaytime and On-Call Cover Remuneration Policy for Non Training Grade Medical Staff
Daytime and On-Call Cover Remuneration Policy for Non Training Grade Medical Staff Who Should Read This Policy Target Audience Consultants Staff Grades and Associate Specialists (SAS Doctors) Line Managers
More informationStandard Operating Procedure for Archiving
Standard Operating Procedure for Archiving SOP name: NWORTH07/19 archiving Version 2 Authorship Team: Angela Gliddon & Rhiannon Whitaker Meeting date reviewed 16 th April 2008 Designated NWORTH member
More informationRANGE INTERNATIONAL LIMITED CODE OF CONDUCT
RANGE INTERNATIONAL LIMITED CODE OF CONDUCT 1. PURPOSE 2. SCOPE The Range Code of Conduct outlines a set of general business ethics that apply to all employees when conducting any activity relating to
More informationQualified Persons in the Pharmaceutical Industry. Code of Practice. March 2008
Qualified Persons in the Pharmaceutical Industry Code of Practice March 2008 Updated October 2009 Code of Practice for Qualified Persons 1. INTRODUCTION... 1 2. REGULATORY BASIS FOR THE QUALIFIED PERSON...
More informationInspections: an academic perspective
Inspections: an academic perspective Patricia Henley Quality and Governance Manager Head, Research Governance & Integrity Office London School of Hygiene & Tropical Medicine Email: patricia.henley@lshtm.ac.uk
More informationPostNL group procedure
1 January 2017 PostNL Holding B.V. Audit & Security PostNL group procedure on fraud prevention guidance on bribery and corruption Author Director Audit & Security Title PostNL group procedure on Fraud
More informationPOLICY ON MANAGING POLICIES, PROCEDURES AND GUIDANCE DOCUMENTS
POLICY ON MANAGING POLICIES, PROCEDURES AND GUIDANCE DOCUMENTS Version: 6 Date Ratified: February 2017 Review Date: February 2020 Applies to: Senior Managers and staff who produce procedural documents.
More informationGlobal Supplier Code of Conduct
Global Supplier Code of Conduct Message from our Chief Executive Officer At Rolls-Royce our strategy focuses on customer, innovation and profitable growth to ensure a sustainable business. This includes
More informationPOLICY FOR THE MANAGEMENT OF ABSENCE DUE TO SICKNESS
Directorate of Organisational Development & Workforce POLICY FOR THE MANAGEMENT OF ABSENCE DUE TO SICKNESS Reference: OWP007 Version: 1.0 This version issued: 31/05/12 Result of last review: N/A Date approved
More informationRegulation pertaining to disciplinary & related procedures for academic staff
Regulation pertaining to disciplinary & related procedures for academic staff Table of Contents 1. Application... 2 2. Introduction... 2 3. General Principles... 2 4. Investigation... 3 5. Informal guidance
More informationData Protection Policy
Data Protection Policy StCH Data Protection Policy - POL 53 vs1 - July 2016 1 Document Control Table Document Title: Data Protection Policy Document Ref: POL 53 Author (name and job title): Karen Anderson,
More informationAuditing of Swedish Enterprises and Organisations
Auditing of Swedish Enterprises and Organisations March 1st 2018 version 2018:1 1 General Application 1.1 These General Terms govern the relationship between the auditor ( the Auditor ) and the client
More informationUNIVERSITY OF ST ANDREWS STUDENTS ASSOCIATION STAFF DISCIPLINARY PROCEDURE
UNIVERSITY OF ST ANDREWS STUDENTS ASSOCIATION STAFF DISCIPLINARY PROCEDURE 1. Introduction 1.1 In the Association, as in any organisation, issues may arise in relation to staff conduct. In the first instance
More informationIMP Management and Accountability
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationSICKNESS ABSENCE POLICY. Version 8 Final HR Business Partners
SICKNESS ABSENCE POLICY Version 8 Final HR Business Partners Policy Review Alignment Group 23 November 2016 CONTENTS 1 PREFACE 4 2 INTRODUCTION 4 3 SCOPE 4 4 KEY PRINCIPLES 4 5 KEY ROLES & RESPONSIBILITIES
More information10.3 MANAGING DISCIPLINE
ABERDEEN CITY COUNCIL 10.3 MANAGING DISCIPLINE POLICY & PROCEDURE Issue Number Date Approved Pages Amended 4 30 October 2012 4, 6, 8, 9 and 10 Originator Approved By KF/KT LNCT Contents Section 1: Introduction
More informationINSERT TITLE AND BRANDING Dr A Gill s signature and front cover to be placed on policy when received from Communications. (Policy fully ratified)
Disciplinary Policy INSERT TITLE AND BRANDING Dr A Gill s signature and front cover to be placed on policy when received from Communications. (Policy fully ratified) Consultation Staff Forum August 2014
More informationBOARD CHARTER Introduction Company Board Responsibilities
BOARD CHARTER Introduction The directors are accountable to the shareholders and must ensure that Ausdrill Limited ( Company ) is appropriately managed to protect and enhance the interests and wealth of
More informationHuman Samples in Research
Human Samples in Research Import and Export of Human Tissue Document Identifier HTA-06-SOP-Import and Export AUTHOR APPROVER EFFECTIVE DATE: Name and role Signature and date Name and role Signature and
More informationTerms of Engagement SW London Collaborative Staff Bank
Terms of Engagement SW London Collaborative Staff Bank In joining the South West London Collaborative Staff Bank, you agree to the following terms which govern the arrangements under which you may be offered
More informationSICKNESS ABSENCE POLICY
SICKNESS ABSENCE POLICY Implementation Date: 01 April 2013 Review Date: 01 April 2016 April 2013 V1.0 Page 1 of 12 Contents POLICY OVERVIEW... 3 Purpose... 3 Who this Policy applies to... 3 Key Principles...
More informationPERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES
PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 19 Items 25, 26 Item 29 Update to the Publication requirements Update of Submission Timetable
More informationLead Employer Flexible Working Policy. Trust Policy
Lead Employer Flexible Working Policy Type of Document Code: Policy Sponsor Lead Executive Recommended by: Trust Policy Deputy Director of Human Resources Director of Human Resources Date Recommended:
More informationHuman Resources People and Organisational Development. Disciplinary Procedure Manual Staff
Human Resources People and Organisational Development Disciplinary Procedure Manual Staff December 1998 Revised November 2015 Contents 1. Purpose and Scope... 3 2. General Principles... 3 3. Procedure...
More informationHouse of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data
House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research
More informationData Protection Policy
Reference: Date Approved: April 2015 Approving Body: Board of Trustees Implementation Date: August 2015 Supersedes: 2.0 Stakeholder groups Governance Committee, Board of Trustees consulted: Target Audience:
More informationBOARD CHARTER TOURISM HOLDINGS LIMITED
BOARD CHARTER TOURISM HOLDINGS LIMITED INDEX Tourism Holdings Limited ( thl ) - Board Charter 2 1. Governance at thl 2 2. Role of the Board 3 3. Structure of the Board 4 4. Matters Relating to Directors
More informationBury Local Care Organisation Provider Alliance
Job Description Post: Project Manager Band: 6 Location/Base: Responsible to: Main Contacts: Bury Town Centre Senior Programme Manager Bury Local Care Organisation Provider Alliance Job Summary The Project
More informationABSENCE MANAGEMENT POLICY
ABSENCE MANAGEMENT POLICY Policy Folder & Policy Number Human Resources Folder 1: Policy No. 1.1 Version: 1 Ratified by: Stoke CCG Governing Body Date ratified: 24 th September 2013 Name of originator/author:
More informationSTAFF APPRAISAL AND MANAGEMENT SUPERVISION POLICY
STAFF APPRAISAL AND MANAGEMENT SUPERVISION POLICY Version: 6 Ratified by: Date ratified: March 2016 Title of originator/author: Title of responsible committee/group: Date issued: March 2016 Review date:
More informationRisk Management Briefing
Risk Management Briefing Guidance on the Bribery Act 2010 Revised April 2017 Introduction The offence of bribery has existed for a considerable period in the UK, but prior to 2011 proved difficult to enforce
More informationEqual Opportunities POLICY AND PROCEDURE. Solihull Life Opportunities INTRODUCTION
Solihull Life Opportunities POLICY AND PROCEDURE Equal Opportunities 38 Walnut Close, Chelmsley Wood, Birmingham, B37 7PU Charity No. 1102297 England Company No. 5025939 INTRODUCTION Solihull Life Opportunities
More informationABSENCE MANAGEMENT POLICY
ABSENCE MANAGEMENT POLICY REFERENCE NUMBER Absence Management Policy VERSION V1.0 APPROVING COMMITTEE & DATE Clinical Executive Committee 17.6.15 REVIEW DUE DATE May 2018 CONTENTS 1. Policy statement 1
More informationDIGNITY AND RESPECT POLICY AND GUIDELINES ON PREVENTING AND MANAGING WORKPLACE BULLYING
DIGNITY AND RESPECT POLICY AND GUIDELINES ON PREVENTING AND MANAGING WORKPLACE BULLYING Foreword: Director General, NSW Premier s Department The New South Wales Government is committed to ensuring its
More informationINFORMATION GOVERNANCE STRATEGY IMPLEMENTATION PLAN
INFORMATION GOVERNANCE STRATEGY & IMPLEMENTATION PLAN 2015-2018 Disclaimer The latest version of this document is located on PTHB intranet. Please check the review date and if there are any doubts contact
More informationRecruitment and Selection Policy and Procedure
Recruitment and Selection Policy and Procedure Date Impact Assessed: March 2014 Version No: 1 No of pages: 14 Date of Issue: Date of next review: April 2015 Distribution: All employees Published: Recruitment
More informationInformation Governance Policy
Information Governance Policy Version: 4.0 Ratified by: NHS Bury Clinical Commissioning Group Information Governance Operational Group Date ratified: 19 th September 2017 Name of originator /author (s):
More informationGuidelines for managing test incidents in schools
Guidelines for managing test incidents in schools 2018 Table of contents Guidelines for managing test incidents in schools... 2 Supporting NAPLAN test integrity... 2 1. Preamble... 2 1.1. Overview... 2
More informationHuman Resources Policy Framework. Management of Attendance Policy and Procedure
Human Resources Policy Framework Management of Attendance Policy and Procedure Approved by: Cabinet Resources Panel (15.12.2015) revised Cabinet Resources Panel (27.11.2012) original Published: 01.01.2016
More informationSTUDY CLOSURE AND ARCHIVING
STUDY CLOSURE AND ARCHIVING DOCUMENT NO.: CR009 v2.0 AUTHOR: Lynn Smith ISSUE DATE: 15 August 2016 EFFECTIVE DATE: 29 August 2016 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research
More informationS.D.F ELECTRICAL PTY LTD ABN EMPLOYEE POLICY BOOKLET
S.D.F ELECTRICAL PTY LTD EMPLOYEE POLICY BOOKLET 2017 S.D.F ELECTRICAL PTY LTD BLANK PAGE S.D.F Electrical Pty Ltd BUSINESS OBJECTIVES KEY POLICIES ASSOCIATED PROCEDURES Working Live Establishing Employee
More informationRISK MANAGEMENT STRATEGY
Agenda Item No: 15 RISK MANAGEMENT STRATEGY PURPOSE: The Risk Management Strategy has been updated to reflect the revised approach to the Corporate Risk Register and Board Assurance Framework and to reflect
More informationData Protection. Policy
Data Protection Policy Why do we need this policy? What does the policy apply to? Which parts of SQA are affected? SQA is committed to adopting best practice in protecting the personal information of all
More informationSickness Absence Policy Implementation Date: 01 April 2013 Review Date: 01 April 2016
Sickness Absence Policy Implementation Date: 01 April 2013 Review Date: 01 April 2016 1 P age AMENDMENT HISTORY VERSION DATE AMENDMENT HISTORY D1 Sept 13 Addition of branding and formatting changes in
More informationLABCORP SUPPLIER CODE OF CONDUCT
LABCORP SUPPLIER CODE OF CONDUCT 1 TABLE OF CONTENTS Introduction It s All About Teamwork...3 Supplier Code of Conduct Program Elements How Does the Code Work?...4 Ethics and Compliance...5-6 Labor and
More informationThe EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria Question 1: What laws or regulations apply to an application for conducting a clinical
More informationCorporate Governance in the NHS. Code of Conduct Code of Accountability
Corporate Governance in the NHS Code of Conduct Code of Accountability Contents Code of Conduct for NHS Boards Public Service Values... 2 General Principles... 2 Openness and Public Responsibilities...
More informationScotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG
Scotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone: 0131-465-5679 19 February 2016 Professor Karim Brohi Professor of Trauma Science Queen Mary University of London
More informationHours of Work: 37.5 hours per week (part time hours negotiable)
JOB DESCRIPTION Post Title: Head of Performance Assurance Location: NHS Oldham CCG Headquarters (Ellen House) Salary/Grade: Band 8c Hours of Work: 37.5 hours per week (part time hours negotiable) Type
More informationLeeds Interagency Protocol for Sharing Information
Leeds Interagency Protocol for Sharing Information The Protocol An inter-agency initiative to provide a framework for sharing personal information about service users between health and social care organisations
More informationCODE OF ETHICS AND PROFESSIONAL CONDUCT
CODE OF ETHICS AND PROFESSIONAL CONDUCT Preamble Members of The American Institute of Architects are dedicated to the highest standards of professionalism, integrity, and competence. This Code of Ethics
More informationBoard Charter Z Energy Limited
Board Charter Z Energy Limited Z Energy Limited ( Z Energy ) is committed to the highest standards of corporate governance. This Board Charter ( Charter ) is the foundation document which sets out the
More informationComputer Programs and Systems, Inc. Code of Business Conduct and Ethics
(as of January 28, 2013) Introduction This sets forth the guiding principles by which we operate Computer Programs and Systems, Inc. (the Company ) and conduct our daily business with our stockholders,
More informationRELM WIRELESS CORPORATION (the Company ) CODE OF BUSINESS CONDUCT AND ETHICS
RELM WIRELESS CORPORATION (the Company ) CODE OF BUSINESS CONDUCT AND ETHICS Introduction This Code of Business Conduct and Ethics covers a wide range of business practices and procedures. It does not
More informationGuidance on conducting consultations in the HRA Internal HRA guidance only
Guidance on conducting consultations in the HRA Internal HRA guidance only Author: Amanda Hunn Date of Release: 19 th February 2015 Version No. & Status: v.1.0 Final Approved by: EMT Supersedes Version:
More informationCorporate Governance Statement John Bridgeman Limited
Corporate Governance Statement John Bridgeman Limited 1 Definition In this document: ASX Board Chair CFO Company Secretary Corporations Act Director means ASX Limited ACN 008 624 691 or the securities
More informationCORPORATE GOVERNANCE POLICY
CORPORATE GOVERNANCE STATEMENT Atlantic is committed to building a diversified portfolio of resources assets that deliver superior returns to shareholders. Atlantic will seek to achieve this through strong
More informationPrimary Care mcta 2013: Guidance for use
GUIDANCE ON USE OF THE MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY SPONSORED RESEARCH IN PRIMARY CARE (PRIMARY CARE mcta, 2013 VERSION) Background to the development
More informationCODE OF CONDUCT Business ethics and compliance
CODE OF CONDUCT Business ethics and compliance BUSINESS PARTNERS Index FRESENIUS KABI BUSINESS PARTNER CODE OF CONDUCT 3 ABOUT US 4 FRESENIUS KABI S BUSINESS: CARING FOR LIFE FRESENIUS KABI S CORE VALUES
More informationDiscipline Policy and Procedure. Adopted by the Trust Board on 6 December 2016
Discipline Policy and Procedure Adopted by the Trust Board on 6 December 2016 1 P a g e Whole Trust Discipline Policy and Procedure Contents 1. Purpose... 2 2. General Principles... 2 3. Acceptable Behaviour
More informationEquality & Diversity Policy and Procedure
Equality & Diversity Policy and Procedure Contents 1. Policy Statement 2. Purpose and Scope 3. The Definition of Equality and Diversity 4. Forms of Discrimination 5. Legislative and Regulatory Context
More information